Clariscan

Clariscan 0.5 mmol/mL Injection Solution

Qualitative and Quantitative Composition:
Each mL contains 279.3 mg gadoteric acid* (as gadoterate meglumine), equivalent to 0.5 mmol, as the active substance, and 202.46 mg tetraxetan (DOTA) and 90.62 mg gadolinium oxide as excipients.
*Gadoteric acid: a complex of gadolinium with 1,4,7,10 tetraazacyclododecane N,N',N'',N''' tetraacetic acid (tetraxetan (DOTA))
Macrocyclic, Gadolinium-based MRI contrast agent

Commercial Presentations:
1x10 mL Vial
1x15 mL Vial
1x20 mL Vial